Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Short Interest Down 26.7% in November

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRFGet Free Report) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 76,700 shares, a drop of 26.7% from the November 15th total of 104,700 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Surgical Science Sweden AB (publ) Stock Performance

Shares of SUSRF remained flat at $12.75 during mid-day trading on Friday. The company’s 50-day simple moving average is $12.15 and its 200 day simple moving average is $12.32. Surgical Science Sweden AB has a 12-month low of $11.30 and a 12-month high of $14.30.

About Surgical Science Sweden AB (publ)

(Get Free Report)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.

Read More

Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.